DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets blister

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

desvenlafaxine, Quantity: 100 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

Desvenlafaxine

forme pharmaceutique:

Tablet, modified release

Composition:

Excipient Ingredients: magnesium stearate; hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black

Mode d'administration:

Oral

Unités en paquet:

28, 7, 14

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.

Descriptif du produit:

Visual Identification: Dark brown to red colored, diamond shaped, biconvex tablets, debossed with 'Ll90' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-11-26